Updated:
Life Sciences Greenhouse of Central Pennsylvania
The Life Sciences Greenhouse of Central Pennsylvania emerged from a 2002 state initiative that carved Pennsylvania into three investment zones, each with...
Life Sciences Greenhouse of Central Pennsylvania
The Life Sciences Greenhouse of Central Pennsylvania emerged from a 2002 state initiative that carved Pennsylvania into three investment zones, each with a dedicated commercialization engine. Thomas S. Grogan leads the central Pennsylvania operation, succeeding founding CEO Melvin L. Billingsley. The Pennsylvania Department of Community and Economic Development provides oversight and funding, making the greenhouse a hybrid: part economic development vehicle, part venture investor. The firm deploys capital across biotechnology, medical devices, diagnostics, and healthcare IT, targeting pre-seed through Series A companies spun out of Penn State, Penn State Hershey, and other regional research institutions. It co-invests frequently with Ben Franklin Technology Partners, another state-backed network. The greenhouse takes equity positions and provides commercialization grants, though specific portfolio holdings remain closely held. Its geographic mandate spans 31 counties, from the Susquehanna Valley through the Northern Tier. The management team includes Senior Vice President Kevin Harter, a co-founder, and Vice President of Venture Operations Stephen Carpenter. The greenhouse maintains dual offices on Front Street and Market Street in Harrisburg. It participates in Life Sciences Pennsylvania, the regional trade association, and the Association of University Technology Managers, reflecting its focus on technology transfer from lab to market. The greenhouse's architecture as a state-funded, regionally bounded investor creates a structural differentiator: it must balance fiduciary returns with legislative mandates for job creation and economic development in a specific geography. This tension shapes every investment decision — a discipline rare among pure-play venture firms but common across Pennsylvania's three-greenhouse system.
General information
Firm type
Generalist
Year founded
—
AUM
Undisclosed
Location
Region
North America
Country
United States
City
Harrisburg
Corporate office
225 Market Street, Suite 500, Harrisburg, PA 17101, United States
Additional offices
3211 N Front St Ste 201, Harrisburg, PA 17110
Principals
Thomas S. Grogan
President and CEO
Melvin L. Billingsley
Former President and CEO
Kevin Harter
Senior Vice President and Co-founder
Stephen Carpenter
Vice President of Venture Operations
Sector focus
Frequently asked questions
Who runs investment decisions at Life Sciences Greenhouse of Central Pennsylvania?
Thomas S. Grogan serves as President and CEO, leading investment strategy and operations. Kevin Harter, Senior Vice President and co-founder, and Stephen Carpenter, Vice President of Venture Operations, round out the senior team. Melvin L. Billingsley previously held the CEO role before Grogan.
How is Life Sciences Greenhouse of Central Pennsylvania funded?
The Pennsylvania Department of Community and Economic Development provides state funding and oversight. The greenhouse also pursues institutional partnerships and co-investment relationships. This public backing distinguishes it from privately capitalized venture firms.
What is the greenhouse's relationship to Ben Franklin Technology Partners?
Ben Franklin Technology Partners is a frequent co-investment partner. Both entities operate with Pennsylvania state backing but maintain separate organizational structures and geographic or functional mandates. Their co-investments provide portfolio companies with layered state support.
What geographic areas does the greenhouse cover?
The firm covers a 31-county region in central Pennsylvania, anchored by research institutions including Penn State and Penn State Hershey. This region spans from the Susquehanna Valley through the Northern Tier, making the greenhouse the primary life sciences commercialization vehicle for the area.
What types of companies does the greenhouse back?
The firm invests in early-stage life sciences companies — pre-seed through Series A — in biotechnology, medical devices, diagnostics, and healthcare IT. It provides both equity investments and commercialization grants, typically targeting university spinouts and startups within its 31-county mandate.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: